ArticleBMC musculoskeletal disorders2025
Risk factors for implant failure of PFNA-II in the treatment of intertrochanteric fractures (AO/OTA 31 A1 and A2).
Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Early Mechanical Dissociation of Helical Blade-Barrel Interface in Proximal Femoral Nail: A Case Report.Journal of orthopaedic case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundIntertrochanteric fractures are common in the elderly, with PFNA being the primary treatment. The shorter PFNA-II is frequently used in Asian populations, but its failure risk factors remain unclear. This study aims to explore these factors to guide clinical treatment.
methodsA retrospective study was conducted on 693 intertrochanteric fracture patients treated with PFNA-II. Patients were divided into two groups based on implant failure. Reduction quality, continuity of the medial femoral cortex, nail length, and tip apex distance (TAD) were analyzed to determine risk factors.
resultsA total of 466 patients were enrolled, with an average age of 83 years old. There were 24 patients with implant failure. There was no significant difference in demographic index between the two groups. After propensity score matching and multivariate logistic regression analysis, there were statistically significant differences in reduction quality and continuity of the medial femoral cortex between the two groups. Poor reduction quality significantly increased the risk of implant failure by 22.2 times, while discontinuity of the medial femoral cortex increased this risk by 12.1 times.
conclusionPoor reduction quality and medial femoral cortex discontinuity are key risk factors for implant failure in intertrochanteric fractures treated with short PFNA-II, increasing failure risk by 22.2 and 12.1 times respectively. Anatomic reduction and medial support reconstruction are crucial for successful outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.